Amy Goundry Takes on The Role of Managing Editor for Therapeutic Advances in Cardiovascular Disease
Amy Goundry, Managing Editor at Sage, shared on LinkedIn:
”I’ve recently taken on the role of Managing Editor for Therapeutic Advances in Cardiovascular Disease, a gold open access journal dedicated to advancing clinical care across the full spectrum of cardiac and circulatory conditions.
The journal is shaped by a global community of researchers and clinicians who care about evidence that informs real treatment decisions — from pharmacological innovations to interventional strategies and other therapeutic approaches that move us closer to precision cardiovascular care.
Always glad to connect with researchers and clinicians helping to shape the conversation in cardiovascular care — whether by sharing their research or contributing to the journal’s editorial community!”
Find the Journal here.
Stay updated with Hemostasis Today.
-
Sep 6, 2026, 18:17Aryabhatta Sadhu: Irradiation of Blood Components – From Clinical Indication to Laboratory Release
-
Sep 6, 2026, 18:15Ashenafi Tazebew Amare: A Year of Progress, Transformation and Renewed Commitment
-
Sep 6, 2026, 18:13Emilio Osorio: Can Anticoagulation Be Safely Discontinued After Surgical Left Atrial Appendage Occlusion?
-
Sep 6, 2026, 18:11Razan Alolyani: Our Research on Anticoagulation After Acute Ischemic Stroke Receives 2nd Place
-
Sep 6, 2026, 18:10Chayakrit Krittanawong: Have You Heard of Blood Clots in the Legs?
-
Sep 6, 2026, 18:08Trilok Chand: Microplastics Found in Human Testes and Blood Clots
-
Sep 6, 2026, 18:07Sarah Moharem Elgamal: Cardiovascular Imaging Beyond Anatomy Toward Earlier Risk Prediction
-
Sep 6, 2026, 16:41Christina P.: APS – How it Happens in Your Blood, the Warning Signs, and What to Do about It
-
Sep 6, 2026, 16:33Jose Angel Nicolas Avila: How Tissue Mitochondrial Activity Dictates Macrophage Pool Size